Literature DB >> 11298345

CD95 is required for the early control of parasite burden in the liver of Leishmania donovani-infected mice.

C E Alexander1, P M Kaye, C R Engwerda.   

Abstract

In this study we show an increased incidence of T cell apoptosis in the liver and spleen of mice infected with Leishmania donovani. T cells from L. donovani-infected mice were found to be increasingly susceptible to CD95-mediated apoptosis in vitro, compared to controls. To test if suboptimal T cell function resulting from CD95-mediated apoptosis contributes to sustained parasite burden in L. donovani parasitized mice, B6.gld mice (lacking functional CD95 ligand) were infected with L. donovani. Surprisingly, at four different time points no difference in levels of T cell apoptosis in the spleen and liver was found between these mice and controls following intravenous delivery of L. donovani amastigotes, indicating that the CD95 / CD95L interaction is not essential for T cell apoptosis in the L. donovani-infected liver and spleen. However, B6.gld mice were increasingly susceptible to L. donovani infection, associated with less efficient granuloma formation in the liver and uncontrolled parasite growth in the spleen. Late in infection (day 56 post-infection), B6.gld mice had higher numbers of IFN-gamma-producing CD4(+) T cells in the liver and spleen, indicating a role for CD95 signaling in the homeostasis of this subset of cytokine-producing T cells in L. donovani-parasitized mice. Adoptive transfer of CD4(+) and CD8(+) T cells into recombinase activating gene 1 knockout (RAG-1(- / -)) recipients, revealed that CD95L expressed on CD4(+) T cells contributes to early control of L. donovani infection in the liver via mechanisms that are independent of granuloma formation and induction of apoptosis. These results indicate important roles for CD95 and CD95L that are unrelated to regulation of apoptosis in the early control of L. donovani infection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11298345     DOI: 10.1002/1521-4141(200104)31:4<1199::aid-immu1199>3.0.co;2-6

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  15 in total

1.  Inhibition of caspase-8 activity promotes protective Th1- and Th2-mediated immunity to Leishmania major infection.

Authors:  Wânia F Pereira-Manfro; Flávia L Ribeiro-Gomes; Alessandra Almeida Filardy; Natália S Vellozo; Landi V C Guillermo; Elisabeth M Silva; Richard M Siegel; George A Dosreis; Marcela F Lopes
Journal:  J Leukoc Biol       Date:  2013-09-26       Impact factor: 4.962

2.  A role for tumor necrosis factor-alpha in remodeling the splenic marginal zone during Leishmania donovani infection.

Authors:  Christian R Engwerda; Manabu Ato; Sara E J Cotterell; Tracey L Mynott; Asiya Tschannerl; Patricia M A Gorak-Stolinska; Paul M Kaye
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

3.  Distinct roles for lymphotoxin-alpha and tumor necrosis factor in the control of Leishmania donovani infection.

Authors:  Christian R Engwerda; Manabu Ato; Simona Stäger; Clare E Alexander; Amanda C Stanley; Paul M Kaye
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

4.  Immunological perspectives of leishmaniasis.

Authors:  Susanne Nylén; Shalini Gautam
Journal:  J Glob Infect Dis       Date:  2010-05

5.  CD4+ CCR5+ and CD4+ CCR3+ lymphocyte subset and monocyte apoptosis in patients with acute visceral leishmaniasis.

Authors:  Marcella Potestio; Pietro D'Agostino; Giuseppina Colonna Romano; Salvatore Milano; Viviana Ferlazzo; Alessandra Aquino; Gloria Di Bella; Rosalba Caruso; Giuseppe Gambino; Giustina Vitale; Serafino Mansueto; Enrico Cillari
Journal:  Immunology       Date:  2004-10       Impact factor: 7.397

6.  Human Interleukin-32γ Plays a Protective Role in an Experimental Model of Visceral Leishmaniasis in Mice.

Authors:  Leo A B Joosten; Fátima Ribeiro-Dias; Rodrigo Saar Gomes; Muriel Vilela Teodoro Silva; Jéssica Cristina Dos Santos; Christine van Linge; Juliana Machado Reis; Mauro Martins Teixeira; Sebastião Alves Pinto; Miriam Leandro Dorta; Xiyuan Bai; Edward D Chan; Charles A Dinarello; Milton Adriano Pelli Oliveira
Journal:  Infect Immun       Date:  2018-04-23       Impact factor: 3.441

7.  Alteration of Fas and Fas ligand expression during human visceral leishmaniasis.

Authors:  L Eidsmo; D Wolday; N Berhe; F Sabri; I Satti; A M El Hassan; S Sundar; F Chiodi; H Akuffo
Journal:  Clin Exp Immunol       Date:  2002-11       Impact factor: 4.330

8.  Critical roles for LIGHT and its receptors in generating T cell-mediated immunity during Leishmania donovani infection.

Authors:  Amanda C Stanley; Fabian de Labastida Rivera; Ashraful Haque; Meru Sheel; Yonghong Zhou; Fiona H Amante; Patrick T Bunn; Louise M Randall; Klaus Pfeffer; Stefanie Scheu; Michael J Hickey; Bernadette M Saunders; Carl Ware; Geoff R Hill; Koji Tamada; Paul M Kaye; Christian R Engwerda
Journal:  PLoS Pathog       Date:  2011-10-06       Impact factor: 6.823

9.  CD8(+) T cells in leishmania infections: friends or foes?

Authors:  Simona Stäger; Sima Rafati
Journal:  Front Immunol       Date:  2012-01-24       Impact factor: 7.561

10.  Activation of invariant NKT cells exacerbates experimental visceral leishmaniasis.

Authors:  Amanda C Stanley; Yonghong Zhou; Fiona H Amante; Louise M Randall; Ashraful Haque; Daniel G Pellicci; Geoff R Hill; Mark J Smyth; Dale I Godfrey; Christian R Engwerda
Journal:  PLoS Pathog       Date:  2008-02-29       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.